| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |